Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2025-12-24 @ 5:20 PM
NCT ID:
NCT03909750
Eligibility Criteria:
Inclusion Criteria:
* Documented COPD or RLD by qualified Medical Provider
* History of Pulmonary Function Deficits or supplemental oxygen therapy
Exclusion Criteria:
* Cancer of the Lung
* Patient's on chemotherapy or radiation for Cancer (or History within 5 years)
* Inability to comply with Baseline and 6 month post-treatment HDCT lungs
* General health or inability or unwillingness or ability to provide informed consent for study
* History of lung transplantation
* Life expectancy of \<3 months due to concomitant illnesses
* Exposure to any investigational drug of procedure within 1 month prior to study enrollment which may interfere with interpretation of outcomes
* Illness which, in investigator's judgement, may interfere with patient's ability of comply with protocol, compromise patient safety, ability to provide informed consent or interfere with the interpretation of study outcomes.
* Subjects with chronic immunosuppressive or chemotherapeutic medication.
* Known drug or alcohol dependence or other factors which may interfere with study conduct or interpretation of result in opinion of investigators.
* Subjects with documented Alpha 2 Antitrypsin Deficiency (inherited lung and liver disorder)
* Patient with history of Hepatitis (except Hepatitis A history)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03909750
Study Brief:
Protocol Section:
NCT03909750